Resultados da busca - Nicolas Hohmann

  • Mostrando 1 - 9 resultados de 9
Refinar Resultados
  1. 1
    Effects and Risks Associated with Novel Psychoactive Substances

    Effects and Risks Associated with Novel Psychoactive Substances por Nicolas Hohmann, Gerd Mikus, David Czock

    Publicado em 2014
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Midazolam microdose to determine systemic and pre‐systemic metabolic <scp>CYP3A</scp> activity in humans

    Midazolam microdose to determine systemic and pre‐systemic metabolic <scp>CYP3A</scp> activity in humans por Nicolas Hohmann, Franziska Kocheise, Alexandra Carls, Jürgen Burhenne, Walter E. Haefeli, Gerd Mikus

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B

    First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B por Antje Blank, Christoph Markert, Nicolas Hohmann, Alexandra Carls, Gerd Mikus, Thorsten Lehr, Alexander I. Alexandrov, Mathias Haag, Matthias Schwab, Stephan Urban, Walter E. Haefeli

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects

    Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects por Meggy Suarez‐Carmona, Anja Williams, Jutta Schreiber, Nicolas Hohmann, Ulrike Pruefer, Jürgen Krauß, Dirk Jäger, Anna Frömming, Diana Beyer, Dirk Eulberg, Jarf Ulf Jungelius, Matthias Baumann, Aram Mangasarian, Niels Halama

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer

    Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and lo... por Andreas G. Niethammer, Heinz Lubenau, Gerd Mikus, Philipp Knebel, Nicolas Hohmann, Christine Leowardi, Philipp Beckhove, Mustafa Akhisaroğlu, Yingzi Ge, Marco Springer, Lars Grenacher, Markus W. Büchler, Moritz Koch, Jürgen Weitz, Walter E. Haefeli, Friedrich H. Schmitz-Winnenthal

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer

    A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreat... por Friedrich H. Schmitz-Winnenthal, Nicolas Hohmann, Thomas Schmidt, Lilli Podola, Tobias Friedrich, Heinz Lubenau, Marco Springer, Sébastien Wieckowski, Klaus M. Breiner, Gerd Mikus, Markus W. Büchler, Anne-Valérie Keller, Ruhan Koc, Christoph Springfeld, Phillip Knebel, Mariana Bucur, Lars Grenacher, Walter E. Haefeli, Philipp Beckhove

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

    Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma por Jacek Hajda, Barbara Leuchs, Assia L. Angelova, Veronika Frehtman, Jean Rommelaere, Mieke Mertens, Maximilian Pilz, Meinhard Kieser, Ottheinz Krebs, Michael Dahm, Bernard Huber, Christine E. Engeland, Athanasios Mavratzas, Nicolas Hohmann, Jutta Schreiber, Dirk Jäger, Niels Halama, Oliver Sedlaczek, Matthias M. Gaida, Volker Daniel, Christoph Springfeld, Guy Ungerechts

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC

    Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC por Xu Zhou, Jingyu An, Roma Kurilov, Benedikt Brors, Kai Hu, Teresa Peccerella, Stephanie Roessler, Katrin Pfütze, Angela Schulz, Stephan Wolf, Nicolas Hohmann, Dirk Theile, Max Sauter, Jürgen Burhenne, Shigenori Ei, Ulrike Heger, Oliver Strobel, Simon T. Barry, Christoph Springfeld, Christine Tjaden, Frank Bergmann, Markus W. Büchler, Thilo Hackert, Franco Fortunato, John P. Neoptolemos, Peter J. Bailey

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial

    Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial por Friedrich H. Schmitz-Winnenthal, Nicolas Hohmann, Andreas G. Niethammer, Tobias Friedrich, Heinz Lubenau, Marco Springer, Klaus M. Breiner, Gerd Mikus, Jürgen Weitz, Alexis Ulrich, Markus W. Buechler, Frank Pianka, Ulla Klaiber, Markus K. Diener, Christine Leowardi, Simon Schimmack, Leila Sisic, Anne-Valérie Keller, Ruhan Koc, Christoph Springfeld, Philipp Knebel, Thomas Schmidt, Yingzi Ge, Mariana Bucur, Slava Stamova, Lilli Podola, Walter E. Haefeli, Lars Grenacher, Philipp Beckhove

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: